American Journal of Respiratory and Critical Care Medicine · 1995 · 99 citations · 7 references
Life SciencesInternal MedicinePhysiologyHypersensitivityImmunophysiologyPulmonologyPulmonary InflammationRespiratory AllergyRespiratory PathophysiologyAsthma PathophysiologyBronchial SecretionsNeuropeptide DegradationNeuropeptide SecretionVasoactive Intestinal Peptide Signaling
Tracheal and lung parenchymal SP-LI (substance P-like immunoreactivity) and VIP-LI (vasoactive intestinal peptide-like immunoreactivity) content was measured in HPLC-purified tissue extracts from patients with and without asthma. We detected significantly less SP-LI in tracheal tissue from asthmatic than from nonasthmatic patients, whereas parenchymal SP-LI content was not significantly different between these groups. This finding does not support the concept that asthmatic lungs contain excessive amounts of SP. Indeed, lower SP-LI content of tracheal tissues from asthmatic patients may reflect augmented SP release followed by degradation. We detected greater quantities of VIP-LI in tracheal than in parenchymal tissue in both groups, but did not detect significant differences in VIP-LI content in tracheal or parenchymal tissues from asthmatic and nonasthmatic patients. These findings indicate that asthmatic and nonasthmatic lungs contain similar levels of VIP.
7
Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease
Bartolomé R. Celli, Gordon L. Snider, John E. Heffner et al. · 1995 · 3.5K citations
Medicine, Surgery, Exercise Testing +16
A Light and Electron Microscopic Study
Sydney S. Schochet, William F. McCermick, Gerald F. F · 1976 · 1.6K citations
Medicine, Cell Biology, Physics +5
Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics
SL Ollerenshaw, Deborah Jarvis, CE Sullivan et al. · European Respiratory Journal · 1991 · 259 citations · Full text